📋About
Funding research (clinical research fellows, early-phase trials, RNA immunotherapy studies, PhD studentships including mental health/autism/ADHD in young cancer patients, Janet Rooney Fellowship for HPB cancers and NETs); care and treatment (proton beam therapy centre, Total Body PET-CT scanner investment, endoscopy clinic); education; extra patient services (animal therapy — cocker spaniels Lilo and Luna visiting proton beam therapy centre fortnightly); psychological support for Teenage and Young Adult (TYA) unit patients; community and corporate fundraising; events including Festive Dash, Manchester Half Marathon, Night of Neon 5K
Custom geography from upload: Greater Manchester / National
📊Key Metrics
£20.8m raised in 2024-25; 83p in every £1 spent went directly to supporting patients; commitment to invest up to £30m in research by 2030 to treble the number of patients participating in clinical trials
Key Metric 1
Around 60 patients a year now benefiting from early-phase blood cancer clinical trials funded by the Charity; TYA psychological support service has delivered 600+ sessions to 90 young patients (aged 16-24) since launching in late 2022
Key Metric 2
5,354 supporters covered 142,066km across fundraising events; over 25,000 staff from 545+ businesses chose to support the Charity; gifts in Wills support one third of the Charity's projects
Key Metric 3
✅Key Outcomes
- Clinical trial patient Jan Ross is in complete remission from multiple myeloma following charity-funded early-phase trial; patient John McGartland in remission from gastro-oesophageal junction cancer following RNA immunotherapy trial
- £250,000 raised at single fundraising ball funding a clinical PhD into mental health, autism and ADHD in young cancer patients; £100,000+ raised by one family funding The Janet Rooney Fellowship for rare HPB cancers and NETs
- Investment in a state-of-the-art Total Body PET-CT scanner underway — one of only four in the UK — reducing scan time from 20 minutes to 5 minutes and significantly cutting radiation dose to patients